TERMIS 2021 | Addressing issues with developing therapies for hearing loss

Brigitte Malgrange, Pharm.D, PhD, University of Liège, Liège, Belgium, provides an overview of the current challenges associated with generating regenerative therapies for hearing loss. Numerous advancements have been made in the field and therapies based on induced pluripotent stem cells (iSPCs) are becoming more feasible as a result. However, the complex structure of the inner ear results in making the ear less accessible for therapies compared to other areas such as the eye. This interview took place at the 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).